Senior Group Leader
Our group aims to identify novel therapies that target subgroups of lung cancer patients harbouring specific genetic changes.
Prior to coming to Oxford in 2010, Anderson was a Principal Scientist in the Cancer Discovery Department at AstraZeneca based at Alderley Park in Cheshire and before that a University Lecturer at the University of Manchester based at the CRUK Paterson Institute for Cancer Research. He undertook post-doctoral research first at the University of Durham and then at the University of Cambridge.
He is a member of several professional organisations including the American Association for Cancer Research and the American Association for the Advancement of Science and the Genetics Society.
Sivan Bokobza, Postdoctoral researcher
Fiona Cahill, DPhil Student
Aoife Devery, Postdoctoral researcher
Neele Drobnitzky, DPhil Student
Luiza Madia Lourenco, DPhil Student
John Moore, Postdoctoral researcher
Amalina Pg Hj Mumin
Sam Olyha, MRes Student
Yasmin Shanneik, Research Assistant
Tom Verbiest, MRes student)
Rekha Wadekar, Research Assistant
Anika Weber, DPhil student
Mumin NH. et al, (2019), BMC Cancer, 19
Legrand AJ. et al, (2018), Oncotarget, 9, 13666 - 13681
Lourenco LM. et al, (2018), Int J Radiat Oncol Biol Phys, 100, 767 - 775
Drobnitzky N. et al, (2017), MOLECULAR CANCER THERAPEUTICS, 16
Tacconi EM. et al, (2017), EMBO Mol Med, 9, 1398 - 1414